Robert McQuade
Board Member
Robert McQuade (born 1957) is Board member since 2025.
He has more than 40 years of experience in pharmaceutical drug development, including drug discovery, clinical development, regulatory affairs, marketing, strategy development and executive management within Schering-Plough, Bristol-Myers Squibb and Otsuka Pharmaceuticals. Former roles include the position as Associate Director CNS Pharmacology at Schering-Plough Research Institute, Senior Director Neuroscience Global Medical Affairs at Bristol-Myers Squibb and Executive Vice President, Chief Strategic Officer and Interim Chief Medical Officer at Otsuka Pharmaceutical Development and Commercialization.
Robert holds a B.Sc., Biology, from Davidson College, US and a Ph.D. in Biochemical Pharmacology from the University of North Carolina, US.
Other current appointments: Corporate Strategic Advisor for Otsuka America Inc, including being a Member of the Board on Otsuka America Pharmaceutical Inc, Otsuka Pharmaceutical Development and Commercialization Inc, Visterra Inc and Astex Therapeutics Ltd. He is also a Board member for Compass Pathways Ltd.
Holdings in the company: -
Independent in relation to the company and its management and the company’s major shareholders.